Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the rat.
D000818:Animals; D002250:Carbon Radioisotopes; D003342:Corpus Striatum / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D006834:Hydrazines / Q000008:administration & dosage / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D008297:Male; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010293:Pargyline / Q000008:administration & dosage / Q000494:pharmacology; D051381:Rats; D013997:Time Factors; D014191:Tranylcypromine / Q000008:administration & dosage / Q000494:pharmacology; D014316:Tritium; D014443:Tyrosine / Q000378:metabolism
D002250:Carbon Radioisotopes; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D014316:Tritium; D014191:Tranylcypromine; D014443:Tyrosine; D010293:Pargyline; D008995:Monoamine Oxidase; D004298:Dopamine